Management of Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Recommendations of a Multidisciplinary Panel of Experts from South America
Most prostate cancer patients who undergo androgen-deprivation therapy or orchiectomy will eventually develop castration-resistant prostate cancer (CRPC), often preceded by a nonmetastatic CRPC state known as M0CRPC. The recent development of second-generation antiandrogens provides clinicians with...
Guardado en:
Autores principales: | Ray Manneh, Ricardo Brugés, Jose Jaime Correa, Julián Rojas, Daniel Rojas, Nicolás Villareal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/28ebbd61bfad401985badd8042584f0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
[55] Persistent haematuria and intra-prostatic haematoma following prostate biopsy: A novel method of management
por: Abdelrahman Eltafahny, et al.
Publicado: (2018) -
Can androgen-deprivation therapy obviate the need of channel transurethral resection of the prostate in advanced prostate cancer with urinary retention? A prospective study
por: Rajeev Sood, et al.
Publicado: (2017) -
[10] Digital rectal examination: is it essential for the screening of prostate cancer
por: Samir Bouras
Publicado: (2018) -
[81] Correlation between intravesical prostatic protrusion and the failure of medical treatment
por: Redouane Rabii, et al.
Publicado: (2018) -
Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Diaa-Eldin Taha, et al.
Publicado: (2018)